Moreover, elevated GR expression has been significantly correlated with improved overall survival in this patient population [37] Using immunohistochemical analysis, Lu et al. demonstrated that approximately 50% of patients with advanced-stage NSCLC exhibit high GR expression [38]. Here, NR3C1 is linked to non-small cell lung carcinoma.